Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Iodine Radioisotopes
  • Lymphoma, B-Cell
  • Lymphoma, Non-Hodgkin

abstract

  • A single course of iodine I 131 tositumomab was significantly more efficacious than the LQC received by extensively pretreated patients with chemotherapy-refractory, low-grade, or transformed low-grade NHL and had an acceptable safety profile.

publication date

  • October 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11579112

Additional Document Info

start page

  • 3918

end page

  • 28

volume

  • 19

number

  • 19